A 12-week, Randomized, Double-blind, Placebo-controlled Study Assessing the Efficacy of EGHB010, a Standardized Extract of Paeoniae radix and Glycyrrhizae radix, in Patients with Early Age-related Macular Degeneration

Background EGHB010, a standardized extract of Paeoniae radix and Glycyrrhizae radix, inhibits choroidal neovascularization. The aim of this study is to evaluate the efficacy and safety of EGHB010 on early age-related macular degeneration (AMD) progression inhibition. Methods The study was designed as a randomized, double-blind, single-center, placebo-controlled study. Subjects were 50 years of age or older, and early AMD satisfied the criteria...